You are here

Evidence-Based Resource Summary

Strength of Evidence: 
4 out of 4
4 out of 4
Year Published: 
2016

Aspirin to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication in Adults Age 70 Years and Older

Description of Resource: 
The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to assess the balance of benefits and harms of initiating aspirin use for the primary prevention of cardiovascular disease and colorectal cancer in adults age 70 years and older. This is an I statement, which means evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined.

Evidence-Based Resource Details

help Learn more about EBR criteria
Developed By: 
United States Preventive Services Task Force
Developer Type: 
Federal Government
Healthy People 2020 Topic Area(s): 
Cancer
Heart Disease and Stroke
Resource Type: 
Systematic Review
Citation: 
U.S. Preventive Services Task Force. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication [Internet]. 2016 Apr [cited 2017 Sept 8]. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer?ds=1&s=aspirin%20cardiovascular